预览加载中,请您耐心等待几秒...
1/10
2/10
3/10
4/10
5/10
6/10
7/10
8/10
9/10
10/10

亲,该文档总共75页,到这已经超出免费预览范围,如果喜欢就直接下载吧~

如果您无法下载资料,请参考说明:

1、部分资料下载需要金币,请确保您的账户上有足够的金币

2、已购买过的文档,再次下载不重复扣费

3、资料包下载后请先用软件解压,在使用对应软件打开

PartfourDiseasesofDigestiveSystemChapter15HepatocellularCarcinomaOverviewDefinitionHeaptocellularcarcinoma(HCC)originatedinthelivercellsorintrahepaticbileductcells.Incidencerate14.58~46/100,000.HCCisupto2~5timesmorecommoninmenthanwomenandusuallyarisesinacirrhoticliver.ChronicliverdiseaseAflatoxinDrinkingWaterPollutionOtherfactorsChronicliverdiseaseviralhepatitis1.HBV:HBV-DNAmaybeintegratedintothehostDNAoflivercells,andchangesgeneexpressioninlivercells.2.HCVCirrhosisAbout50~90%ofHCCaccompaniedcirrhosis.Acuteandchronichepatitis→Cirrhosis→HCCAflatoxinB1DrinkingWaterPollution:AlgaetoxincouldcontaminatewatersourcesChemicalcarcinogens:nitrite,organicchlorinepesticidesParasite:liverflukePathologyMorphologicaltypingBlocktype(>5cm)Nodulartype(<5cm)DiffusetypeSmallhepatocarcinoma(<3cm)CellclassificationHepatocellularBileductcelltypemetastasis1.Intrahepaticmetastasis2.Extrahepaticmetastasis(1)Hematogenousmetastasis(2)Lymphaticmetastasis(3)implantationmetastasisSubclinicalhepatocellularcarcinoma:WithoutanysignsandsymptomsAFPhepaticregionpain:PersistentpainordullpainProgressiveenlargeliver:Qualityhard,unevensurface,noduleorgiantblocks,raggededge,tenderness,vascularmurmurJaundiceCirrhosissymptomsandsigns:liverdysfunctionandPortalhypertension:SuchasSplenomegaly,ascites,collateralcirculationSystemicmanifestationsofmalignanttumors:Fatigue,weightloss,cachexia,fever,anorexiaMetastasisfeatures:thelung,bone,chestParaneoplasticsyndrome:suchashypoglycemia、ErythrocytosisandsoonSYMPTOMS(一)Detectionoflivercancermarkers1.Alpha-fetoprotein(AFP)ClinicalSignificance:livercancercensus(high-riskgroups),diagnosis,JudgingtreatmentandrelapseAFPdiagnosticcriteriaforlivercancerAFP>500μg/L>4WAFP:FromlowtohighAFP>200μg/L>8WFalsepositive:Pregnancy,chronichepatitis,cirrhosis,GonadalblastomaFalse-negative:DetectionofAFPheterogeneity2.Otherlivercancermarkerr-glutamyltransferaseisoenzymepeptide(r-GT)abnormalprothrombin(APT)seruma-l-fucosidase(AFU)ALPisoenzyme(ALP-I)(